6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
2m ago	Chemours Announces Second Quarter Dividend
1h ago	Fermi Responds to Former CEO's Attempts to Take Control of Board and Reverse Board Actions Taken in Accordance with Their Fiduciary Duties to Remove Him as CEO and Terminate Him for Cause
1h ago	Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue
1h ago	MiTAC Computing Accelerates AI Innovation at AI Expo Korea 2026
1h ago	Moody's Reaffirmed Afya's AAA.br Rating With a Stable Outlook

About

Onkure Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update

OnKure Therapeutics to Participate in Upcoming Investor Conferences

OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update

Recent Videos

OnKure Therapeutics, Inc. (OKUR) #target_biologically_validated_drivers_of_cancers

OnKure Therapeutics, Inc. (OKUR) #target_biologically_validated_drivers_of_cancers

Jan 31, 2026

OKUR Stock BREAKING: What does this mean? (buy?) Onkure Therapeutics

OKUR Stock BREAKING: What does this mean? (buy?) Onkure Therapeutics

May 15, 2025

Community Chat

Ask AI